Tesamorelin plus ipamorelin blend- Do I need to cycle them?

Fernando Almaguer

Well-Known Member
Hello,

Is it necessary to go 5 or 6 days on with a day or two off to reset sensitivity? I see the study in HIV patients did daily continous injections for a year. Remarkable effects on visceral fat and adipocyte quality. Any user experiences or other knowledge is welcomed please!
 
When Ive used any of the GH secretors I have not taken an off day in an 8-12 week time frame. I'm currently using 1295 w/o DAC + Ipamorelin in the 250mcg range each day.
 
When Ive used any of the GH secretors I have not taken an off day in an 8-12 week time frame. I'm currently using 1295 w/o DAC + Ipamorelin in the 250mcg range each day.
Thanks for your comment! Have you noticed drop in fat increase muscle mass. I'm going to consider runnin it more often than the 5 day 2 off split.
 

TESAMORELIN


Long-term efficacy maintained:​


Clinical studies demonstrate that tesamorelin treatment resulted in sustained decreases in visceral adipose tissue over 52 weeks without loss of effectiveness.


The reduction in visceral adipose tissue was maintained in patients who continued treatment until week 52 in extension phases of clinical trials Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy - PubMed.


Does NOT suppress endogenous GH production:​


Tesamorelin activates growth hormone-releasing hormone receptors in the pituitary, which leads to synthesis and release of growth hormone Tesamorelin - LiverTox - NCBI Bookshelf - it stimulates rather than replaces.


Unlike direct human growth hormone injections, tesamorelin maintains the natural feedback loop of the hypothalamic-pituitary axis, with lower risk of growth hormone receptor desensitization Tesamorelin For Beginners: Benefits, Dosage, and Peptide Stacking Tips – Swolverine.


Effects don't persist after stopping:​


Upon discontinuation of tesamorelin, visceral adipose tissue reaccumulated, indicating effects are sustained only during treatment Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation - PubMed.




IPAMORELIN


Potential for desensitization with continuous use:​


Chronic treatment with ipamorelin in young female rats increased body weight gain and enhanced in vitro basal and ipamorelin-stimulated growth hormone release, with results suggesting that ipamorelin does not lead to desensitization of the growth hormone response, while growth hormone-releasing hormone produces desensitization in vitro (PDF) Chronic in vivo Ipamorelin treatment stimulates body weight gain and growth hormone (GH) release in vitro in young female rats.


ANECDOTAL- non- clinical:

Ipamorelin is well-tolerated long-term due to its selective action and low desensitization risk compared to older peptides Ipamorelin Cycle Guide: Optimal Dosage, Timing, and Best Peptide Stack – Swolverine, though sustained use requires cycling protocols, with a typical 12-week cycle including 8 weeks of active dosing followed by a 4-week break to prevent receptor desensitization Ipamorelin Dosage Cycle: How To Plan It – FTW Training.


Does NOT shut down natural GH production:​


Ipamorelin does not suppress the body's own feedback loop or downregulate natural growth hormone production, even with long-term use, making it suitable for extended peptide cycles without risking endocrine shutdown Ipamorelin: What It Is, How It Works, and Why It’s Popular.


Growth hormone secretagogues promote pulsatile release of growth hormone that is subject to negative feedback, which may prevent supratherapeutic levels of growth hormone The Safety and Efficacy of Growth Hormone Secretagogues - PMC.




KEY DIFFERENCE FROM EXOGENOUS GH


Exogenous GH suppresses natural production:​


Previous studies support the concept that exogenous growth hormone can regulate its own secretion through an autofeedback mechanism, with the growth hormone response to growth hormone-releasing factor being significantly inhibited after exogenous growth hormone treatment Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men - PMC.


Exogenous growth hormone administration in humans attenuates the endogenous growth hormone response to pharmacological stimuli, with pretreatment completely blocking the serum growth hormone response to growth hormone-releasing hormone Effect of exogenous growth hormone administration on endogenous growth hormone secretion induced by a met-enkephalin analog - PubMed.


Peptides stimulate, don't replace:​


Growth hormone secretagogues including peptides like sermorelin, ipamorelin, and tesamorelin nudge the body to produce its own growth hormone, maintaining natural rhythms and potentially minimizing risks compared to direct growth hormone supplementation Growth Hormone Peptides: The difference between Sermorelin, Ipamorelin, and Tesamorelin.
 

hCG Mixing Calculator

HCG Mixing Protocol Calculator

TRT Hormone Predictor Widget

TRT Hormone Predictor

Predict estradiol, DHT, and free testosterone levels based on total testosterone

⚠️ Medical Disclaimer

This tool provides predictions based on statistical models and should NOT replace professional medical advice. Always consult with your healthcare provider before making any changes to your TRT protocol.

ℹ️ Input Parameters

Normal range: 300-1000 ng/dL

Predicted Hormone Levels

Enter your total testosterone value to see predictions

Results will appear here after calculation

Understanding Your Hormones

Estradiol (E2)

A form of estrogen produced from testosterone. Important for bone health, mood, and libido. Too high can cause side effects; too low can affect well-being.

DHT

Dihydrotestosterone is a potent androgen derived from testosterone. Affects hair growth, prostate health, and masculinization effects.

Free Testosterone

The biologically active form of testosterone not bound to proteins. Directly available for cellular uptake and biological effects.

Scientific Reference

Lakshman KM, Kaplan B, Travison TG, Basaria S, Knapp PE, Singh AB, LaValley MP, Mazer NA, Bhasin S. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010 Aug;95(8):3955-64.

DOI: 10.1210/jc.2010-0102 | PMID: 20534765 | PMCID: PMC2913038

Beyond Testosterone Podcast

Online statistics

Members online
5
Guests online
618
Total visitors
623

Latest posts

Back
Top